4-Antibody AG

15 articles about 4-Antibody AG

• Agenus (Formerly known as Antigenics Inc. - New York) Completes Acquisition of 4-Antibody AG

  2/13/2014

• Agenus Buys 4-Antibody AG In Potential $50 Million Deal

  1/13/2014

• 4-Antibody AG and the Ludwig Institute For Cancer Research (LICR) Expand Oncology Antibody R&D Program With Three New Targets

  1/29/2013

• 4-Antibody AG Receives Additional Milestone Payments From Human Genome Sciences, Inc.

  10/8/2012

• Evotec AG and 4-Antibody AG Form Strategic Collaboration to Innovate Antibody Selection

  5/9/2012

• 4-Antibody AG Meets Next Milestone in Boehringer Ingelheim Corporation

  9/19/2011

• 4-Antibody AG Forms Collaboration with Human Genome Sciences, Inc.

  8/16/2011

• 4-Antibody AG Forms Multi-target Oncology Research and Development Alliance with the Ludwig Institute For Cancer Research (LICR)

  5/24/2011

• 4-Antibody AG to Relocate to New Labs in Basel

  5/6/2011

• 4-Antibody AG Meets First Milestone in Boehringer Ingelheim Corporation Collaboration

  4/19/2011

• 4-Antibody AG Announces New Board Appointment, Dr Thomas von Ruden

  1/18/2011

• 4-Antibody AG Announces CEO Appointment

  1/11/2011

• 4-Antibody AG Announces a Long-Term Collaboration With Boehringer Ingelheim Corporation for Therapeutic Antibodies; 4-Antibody AG will Receive Payments of up to EUR 177.5 Million

  3/16/2010

• 4-Antibody AG Appoints Dr. Richard Mason as New Chief Executive Officer

  9/26/2008

• 4-Antibody AG Closes CHF 6 Million Series A Financing And Appoints Sijmen de Vries As CEO

  8/21/2006